Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...
Alongside margin recovery, Biocon Biologics has also gained market share, with oncology remaining a key focus area.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback